Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) Cohort

被引:0
|
作者
Bommier, Come [1 ,2 ]
Tsang, Mazie [3 ]
Noble, Brie N. [4 ]
Thompson, Carrie [5 ]
Casulo, Carla [6 ]
Hildebrandt, Michelle [7 ]
Rosenthal, Allison C. [8 ]
Mou, Eric [9 ]
Durani, Urshila [5 ]
Williams, Annalynn M. [10 ]
Yost, Kathleen [11 ]
Larson, Melissa C. [1 ]
Gysbers, Brianna [12 ]
Maurer, Matthew J. [13 ]
Feldman, Andrew L. [14 ]
Jaye, David L. [15 ]
Martin, Peter [16 ]
Cohen, Jonathon B. [17 ]
Chihara, Dai [18 ]
Lossos, Izidore S. [19 ]
Strouse, Christopher [20 ]
Kahl, Brad S. [21 ]
Habermann, Thomas M. [5 ]
Flowers, Christopher R.
Dueck, Amylou Constance [4 ]
Cerhan, James R. [13 ]
机构
[1] Mayo Clin, Div Epidemiol, Rochester, MN USA
[2] Univ Paris Cite, Hematol Oncol, Hop St Louis, Inserm U1153, Paris, France
[3] Mayo Clin, Phoenix, AZ USA
[4] Mayo Clin, Scottsdale, AZ USA
[5] Mayo Clin, Div Hematol, Rochester, MN USA
[6] Univ Rochester, Wilmot Canc Ctr, Rochester, NY USA
[7] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[8] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA
[9] Univ Iowa, Div Hematol Oncol & Blood Marrow Transplantat, Iowa City, IA USA
[10] Univ Rochester, Rochester, NY USA
[11] Mayo Clin, Div Epidemiol, Dept Quantitat Hlth Sci, Rochester, MN USA
[12] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[13] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA
[14] Mayo Clin, Div Hematopathol, Dept Lab Med & Pathol, Rochester, MN USA
[15] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA USA
[16] Weill Cornell Med, Div Hematol & Med Oncol, New York, NY USA
[17] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[18] Univ Texas MD Anderson Canc Ctr Houston, Dept Lymphoma & Myeloma, Houston, TX USA
[19] Univ Miami, Div Hematol, Sylvester Comprehens Canc Ctr, Sch Med, Miami, FL USA
[20] Univ Iowa Hosp & Clin, Div Hematol, Holden Comprehens Canc Ctr, Oncol & Blood Marrow Transplantat, Iowa City, IA USA
[21] Washington Univ St Louis, Sch Med, St Louis, MO USA
关键词
D O I
10.1182/blood-2023-187056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 44 条
  • [31] TREATMENT-RELATED ADVERSE EVENTS WITH NIVOLUMAB IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: RESULTS FROM A COHORT ANALYSIS OF THE PHASE 2 CHECKMATE 205 STUDY.
    Wesson, Emily
    Klebig, Robin
    Stephans, Katherine
    Palmer, Alexandra
    Kurosky, Alanna
    Copeland, Amanda
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [32] Surgical Intervention is Associated with Improvement in Health-Related Quality of Life Outcomes in Patients with Symptomatic Sacral Tarlov Cysts: Results from a Prospective Longitudinal Cohort Study
    Feigenbaum, Frank
    Parks, Susan E.
    Martin, Madelene P.
    Ross, Tanishu D.
    Kupanoff, Kristina M.
    WORLD NEUROSURGERY, 2024, 187 : E189 - E198
  • [33] PRELIMINARY RESULTS OF QUALITY OF LIFE (QOL) ANALYSES FROM THE INTERGROUP PHASE III RANDOMISED TRIAL OF RITUXIMAB VS A WATCH AND WAIT APPROACH IN PATIENTS WITH ADVANCED STAGE, ASYMPTOMATIC, NON-BULKY FOLLICULAR LYMPHOMA (FL)
    Ardeshna, K. M.
    Qian, W.
    Stephens, R.
    Smith, P.
    Warden, J.
    Lowry, L.
    Braganca, N.
    Stevens, L.
    Pocock, C. F.
    Miall, F.
    Cunningham, D.
    Davies, J.
    Walewski, J.
    Jack, A.
    Bradstock, K.
    Linch, D. C.
    ANNALS OF ONCOLOGY, 2011, 22 : 88 - 88
  • [34] Translation, psychometric validation, and baseline results of the Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric measures to assess health-related quality of life of patients with pediatric lymphoma in Malawi
    Westmoreland, Katherine
    Reeve, Bryce B.
    Amuquandoh, Amy
    van der Gronde, Toon
    Manthalu, Olivia
    Correia, Helena
    Stanley, Christopher
    Itimu, Salama
    Salima, Ande
    Chikasema, Mary
    Ward, Paula
    Mpasa, Atupele
    Wachepa, Stella
    Mtete, Idah
    Butia, Mercy
    Chasela, Mary
    Mtunda, Mary
    Wasswa, Peter
    Martin, Steven
    Kim, Nader El-Mallawany
    Kazembe, Peter
    Gopal, Satish
    PEDIATRIC BLOOD & CANCER, 2018, 65 (11)
  • [35] Health-related quality of life and response shift effect of diffuse large B-cell lymphoma French relapse-free patients one year after diagnosis included in prospective real-life REALYSA cohort
    Anota, Amelie
    Charton, Emilie
    Basset, Mathurine
    Efficace, Fabio
    Hafirassou, Hadia
    Bernier, Adeline
    Belot, Aurelien
    Ghesquieres, Herve
    QUALITY OF LIFE RESEARCH, 2024, 33 : S49 - S49
  • [36] CHANGES IN PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE (QOL) IN PATIENTS WITH PERIPHERAL NEUROPATHIC PAIN AFTER A SINGLE TREATMENT OF 8% CAPSAICIN PATCH - RESULTS FROM A SWEDISH 12 WEEK PROSPECTIVE OBSERVATIONAL STUDY
    Hansson, P.
    Magnusson, K.
    Persson, C. A.
    VALUE IN HEALTH, 2012, 15 (07) : A515 - A515
  • [37] Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry
    Ghosh, Nilanjan
    Sharman, Jeff P.
    Gutierrez, Meghan
    Khan, Wasiulla
    Qureshi, Zaina P.
    Raz, Anat
    Girardi, Vincent
    Krigsfeld, Gabriel S.
    Barrientos, Jacqueline C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : e301 - e313
  • [38] HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE PHASE III GALLIUM STUDY OF OBINUTUZUMAB-BASED AND RITUXIMAB-BASED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED INDOLENT NON-HODGKIN LYMPHOMA
    Davies, A.
    Trask, P.
    Demeter, J.
    Florschuetz, A.
    Haenel, M.
    Hong, X.
    Kinoshita, T.
    Pettengell, R.
    Quach, H.
    Robinson, S.
    Sadullah, S.
    Sancho, J. -M.
    Udvardy, M.
    Witzens-Harig, M.
    Rufibach, K.
    Zeuner, H.
    Unterhalt, M.
    HAEMATOLOGICA, 2017, 102 : 190 - 191
  • [39] Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma
    Cheson, Bruce D.
    Trask, Peter C.
    Gribben, John
    Dimier, Natalie
    Kimby, Eva
    Lugtenburg, Pieternella J.
    Thieblemont, Catherine
    Fritsch, Elisabeth Wassner
    Sehn, Laurie H.
    BLOOD, 2015, 126 (23)
  • [40] MyLife: longitudinal assessment of health-related quality of life in patients with multiple myeloma in Germany - first patient-reported outcomes data from MYRIAM, the prospective, national, intersectoral cohort study for treatment and outcome of myeloma patients
    Engelhardt, M.
    Knauf, W.
    Lipke, J.
    Zahn, M. -O.
    Doerfel, S.
    Bittrich, M.
    Reiser, M.
    Sauer, A.
    Aubele, P. O.
    La Rosee, P.
    Houet, L.
    Medinger, T.
    Jaenicke, M.
    Marschner, N.
    Dechow, T.
    Einsele, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 193 - 193